Prognostic factors in triple-negative breast cancer: a retrospective cohort
SUMMARY OBJECTIVE: Triple-negative breast cancer (TNBC) is characterized by lack of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression and accounts for 15–20% of all breast cancers. This study aims to analyze prognostic factors related to a reduction in overall survival (OS), disease-free survival (DFS), and risk of mortality and recurrence in TNBC. METHODS: This is a retrospective observational cohort study. Medical records of 532 patients with breast cancer diagnosed from 2007 to 2020 were analyzed. Of these patients, 93 (17%) were women with TNBC. Ten medical records were excluded, and the final sample was composed of 83 women with TNBC. OS and DFS were estimated by the Kaplan-Meier model. Univariate analysis (log-rank test) and multivariate analysis (Cox regression) were used to examine prognostic factors related to a statistically significant reduction (p<0.05) in OS and DFS and increased risk of mortality and tumor recurrence. RESULTS: Smoking, advanced clinical stage, larger tumor size, angiolymphatic invasion, positive sentinel lymph node, axillary node involvement, higher cancer burden, surgical treatment with mastectomy, and recurrence were related to a significant decrease in OS and/or DFS and increased risk of mortality and/or recurrence in TNBC. The 10-year OS and DFS was around 61 and 65%, respectively. CONCLUSIONS: Advanced clinical stage, positive sentinel lymph node, axillary node involvement, surgical treatment with mastectomy, and higher residual cancer burden were related to a significant reduction in OS and DFS and increased risk of mortality and recurrence in TNBC.
Main Authors: | Costa,Rafael Everton Assunção Ribeiro da, Oliveira,Fergus Tomás Rocha de, Araújo,Ana Lúcia Nascimento, Vieira,Sabas Carlos |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Médica Brasileira
2021
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000800950 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical, histomorphological, and therapeutic prognostic factors in patients with triple-negative invasive breast cancer
by: Lopes,Camila M., et al.
Published: (2015) -
An easy and practical prognostic parameter: tumor–stroma ratio in Luminal, Her2, and triple-negative breast cancers
by: Öztürk,Çiğdem, et al.
Published: (2022) -
Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer
by: Andrade,Fernando, et al.
Published: (2020) -
Triple-negative breast cancer - a retrospective audit of 151 cases seen at the Charlotte Maxeke Johannesburg Academic Hospital Breast Unit
by: Nel,C, et al.
Published: (2022) -
Prognostic variables in node-negative and node-positive breast cancer [electronic resource] /
by: Gasparini, Giampietro. editor., et al.
Published: (1998)